study,id,t,r,n,study_year,unpublished_data,sponsored,rob,unpublished
CL3-20098-022,1,agomelatine,22,133,2001,1,1,2,0
CL3-20098-022,1,fluoxetine,19,137,2001,1,0,2,0
CL3-20098-022,1,placebo,40,149,2001,1,0,2,0
CL3-20098-023,2,agomelatine,23,142,2001,1,1,1,0
CL3-20098-023,2,paroxetine,22,138,2001,1,0,1,0
CL3-20098-023,2,placebo,22,137,2001,1,0,1,0
Kennedy2006 (CL3-20098-043),3,agomelatine,7,107,2003,1,1,1,0
Kennedy2006 (CL3-20098-043),3,placebo,12,105,2003,1,0,1,0
Olie2007 (CL3-20098-042),4,agomelatine,17,118,2004,1,1,1,0
Olie2007 (CL3-20098-042),4,placebo,18,120,2004,1,0,1,0
Stahl2010 (CAGO178A2302),5,agomelatine,78,337,2008,1,1,2,0
Stahl2010 (CAGO178A2302),5,placebo,33,166,2008,1,0,2,0
Zajecka2010 (CAGO178A2301) (NCT00411099),6,agomelatine,74,338,2008,1,1,1,0
Zajecka2010 (CAGO178A2301) (NCT00411099),6,placebo,37,173,2008,1,0,1,0
CL3-20098-024,7,agomelatine,54,301,2002,1,1,1,0
CL3-20098-024,7,fluoxetine,17,148,2002,1,0,1,0
CL3-20098-024,7,placebo,21,158,2002,1,0,1,0
Hale2010 (CL3-20098-045),8,agomelatine,30,252,2008,1,1,1,0
Hale2010 (CL3-20098-045),8,fluoxetine,49,263,2008,1,0,1,0
CL3-20098-026,9,agomelatine,25,109,2001,1,1,1,0
CL3-20098-026,9,placebo,19,109,2001,1,0,1,0
Montgomery2004b (CL3-20098-030),10,agomelatine,35,167,2001,1,1,1,0
Montgomery2004b (CL3-20098-030),10,paroxetine,35,168,2001,1,0,1,0
CL3-20098-036,11,agomelatine,17,137,2004,1,1,1,0
CL3-20098-036,11,venlafaxine,26,140,2004,1,0,1,0
CL3-20098-048,12,agomelatine,52,213,2008,1,1,1,0
CL3-20098-048,12,paroxetine,50,199,2008,1,0,1,0
"Shu2014 (CL3-20098-052, ChiCTR-TRC-11001668) ",13,agomelatine,70,314,2008,1,1,1,0
"Shu2014 (CL3-20098-052, ChiCTR-TRC-11001668) ",13,fluoxetine,75,314,2008,1,0,1,0
"
Quera-Salva2010 (CL3-20098-056)",14,agomelatine,6,71,2008,1,1,1,0
"
Quera-Salva2010 (CL3-20098-056)",14,escitalopram,8,67,2008,1,0,1,0
CL3-20098-062,15,agomelatine,37,202,2010,1,1,1,0
CL3-20098-062,15,duloxetine,35,216,2010,1,0,1,0
Corruble2013 (CL3-20098-063),16,agomelatine,20,164,2008,1,1,1,0
Corruble2013 (CL3-20098-063),16,escitalopram,23,160,2008,1,0,1,0
CL3-20098-070,17,agomelatine,26,151,2011,1,1,1,0
CL3-20098-070,17,placebo,21,71,2011,1,0,1,0
Lemoine2007 (CL3-20098-035),18,agomelatine,16,165,2004,1,1,2,0
Lemoine2007 (CL3-20098-035),18,venlafaxine,36,167,2004,1,0,2,0
CAGO178A2303 (NCT00463242),19,agomelatine,36,169,2008,1,1,2,1
CAGO178A2303 (NCT00463242),19,paroxetine,38,168,2008,1,0,2,1
CAGO178A2303 (NCT00463242),19,placebo,41,166,2008,1,0,2,1
Loo2002 (CL2-014),20,agomelatine,32,137,2002,1,1,2,0
Loo2002 (CL2-014),20,placebo,35,139,2002,1,0,2,0
Loo2002 (CL2-014),20,paroxetine,34,147,2002,1,0,2,0
"Kennedy2014 (EudraCT 2009-011238-84, CL3-20098-069)",21,agomelatine,19,275,2009,1,1,1,0
"Kennedy2014 (EudraCT 2009-011238-84, CL3-20098-069)",21,placebo,15,141,2009,1,0,1,0
Heun2013 (lSRCTl\l5750736O),22,agomelatine,26,151,2009,0,1,1,0
Heun2013 (lSRCTl\l5750736O),22,placebo,21,71,2009,0,0,1,0
Feighner1979,23,amitriptyline,40,93,1979,0,0,1,0
Feighner1979,23,placebo,20,50,1979,0,0,1,0
Thomson1982,29,amitriptyline,9,31,1982,0,0,2,0
Thomson1982,29,placebo,12,28,1982,0,0,2,0
Claghorn1983,30,amitriptyline,32,85,1983,0,0,1,0
Claghorn1983,30,placebo,29,87,1983,0,0,1,0
Stratas1984,31,amitriptyline,2,12,1984,0,0,3,0
Stratas1984,31,placebo,4,10,1984,0,0,3,0
Hormazabal1985,32,amitriptyline,3,20,1985,0,0,1,0
Hormazabal1985,32,placebo,5,20,1985,0,0,1,0
Rickels1985,34,amitriptyline,34,124,1985,0,0,2,0
Rickels1985,34,placebo,59,130,1985,0,0,2,0
Amsterdam1986,35,amitriptyline,13,55,1986,0,0,2,0
Amsterdam1986,35,placebo,21,54,1986,0,0,2,0
Hicks1988,36,amitriptyline,2,16,1988,0,0,2,0
Hicks1988,36,placebo,6,15,1988,0,0,2,0
Gelenberg1990,38,amitriptyline,11,19,1990,0,0,2,0
Gelenberg1990,38,placebo,9,22,1990,0,0,2,0
Bakish1992,41,amitriptyline,19,58,1992,0,0,2,0
Bakish1992,41,placebo,28,56,1992,0,0,2,0
Wilcox1994,45,amitriptyline,22,50,1994,0,0,2,0
Wilcox1994,45,placebo,27,49,1994,0,0,2,0
Mynors-Wallis1995,46,amitriptyline,6,31,1995,0,0,2,0
Mynors-Wallis1995,46,placebo,18,30,1995,0,0,2,0
Chouinard1983a,47,amitriptyline,6,41,1983,0,3,2,0
Chouinard1983a,47,bupropion,18,77,1983,0,3,2,0
Kane1983,48,bupropion,2,13,1983,0,3,1,0
Kane1983,48,placebo,2,7,1983,0,0,1,0
Feighner1984,49,bupropion,10,45,1984,0,1,2,0
Feighner1984,49,placebo,7,22,1984,0,0,2,0
Lineberry1990 (WELL 84A),50,bupropion,25,112,1988,1,1,2,0
Lineberry1990 (WELL 84A),50,placebo,32,112,1988,1,0,2,0
Feighner1991,51,fluoxetine,18,62,1991,0,0,2,0
Feighner1991,51,bupropion,16,61,1991,0,1,2,0
Weisler1994,52,bupropion,26,63,1994,0,1,2,0
Weisler1994,52,trazodone,24,61,1994,0,0,2,0
"Reimherr1998 (WELL203, FDA203)",53,placebo,60,121,1991,1,0,2,0
"Reimherr1998 (WELL203, FDA203)",53,bupropion,53,120,1991,1,1,2,0
Coleman1999 (AK1A4002),55,sertraline,43,118,1998,1,0,2,0
Coleman1999 (AK1A4002),55,placebo,40,124,1998,1,0,2,0
Croft1999 (AK1A4001),56,sertraline,39,119,1998,1,0,1,0
Croft1999 (AK1A4001),56,placebo,41,121,1998,1,0,1,0
Coleman2001 (AK1A4007),57,fluoxetine,57,154,2000,1,0,2,0
Coleman2001 (AK1A4007),57,bupropion,56,150,2000,1,1,2,0
Coleman2001 (AK1A4007),57,placebo,50,152,2000,1,0,2,0
Thase2006 (WELL 100368),60,bupropion,72,171,2005,1,1,2,0
Thase2006 (WELL 100368),60,venlafaxine,81,177,2006,1,0,2,0
Clayton2006b (WELL AK130927),61,escitalopram,33,138,2004,1,3,2,0
Clayton2006b (WELL AK130927),61,bupropion,32,141,2004,1,1,2,0
Clayton2006b (WELL AK130927),61,placebo,39,141,2004,1,0,2,0
Clayton2006a (WELL AK130926),62,bupropion,39,138,2004,1,1,2,0
Clayton2006a (WELL AK130926),62,escitalopram,44,149,2004,1,3,2,0
Clayton2006a (WELL AK130926),62,placebo,32,137,2004,1,0,2,0
Jefferson2006,63,placebo,29,139,2006,0,0,2,0
Jefferson2006,63,bupropion,32,135,2006,0,1,2,0
Hewett2009 (WXL101497),64,venlafaxine,25,189,2005,1,0,1,0
Hewett2009 (WXL101497),64,placebo,32,199,2005,1,0,1,0
Hewett2010b (AK130939),66,venlafaxine,46,198,2005,1,0,2,0
Hewett2010b (AK130939),66,placebo,43,189,2005,1,0,2,0
Wellbutrin 06,67,bupropion,7,56,1978,1,1,1,1
Wellbutrin 06,67,placebo,5,29,1978,1,0,1,1
GSK14,68,bupropion,28,77,1979,1,1,2,1
GSK14,68,placebo,21,40,1979,1,0,2,1
845,69,bupropion,16,56,1980,1,1,2,1
845,69,placebo,10,52,1980,1,0,2,1
WELL 029,70,bupropion,16,25,1984,1,1,2,1
WELL 029,70,placebo,14,24,1984,1,0,2,1
Wellbutrin 25,71,bupropion,46,85,1985,1,1,2,1
Wellbutrin 25,71,placebo,24,43,1985,1,0,2,1
Study 205 (FDA) (WELL 205),72,bupropion,94,239,1993,1,1,2,1
Study 205 (FDA) (WELL 205),72,placebo,39,124,1993,1,0,2,1
WELL AK1A4006,73,fluoxetine,59,155,2000,1,0,2,1
WELL AK1A4006,73,bupropion,62,158,2000,1,1,2,1
WELL AK1A4006,73,placebo,53,154,2000,1,0,2,1
WELL AK140016,74,bupropion,14,69,2001,1,1,2,1
WELL AK140016,74,paroxetine,18,71,2001,1,0,2,1
Study 89306 (FDA),78,citalopram,46,185,1998,1,1,2,1
Study 89306 (FDA),78,placebo,21,89,1998,1,0,2,1
Montgomery1992 (Study 89303 FDA),79,citalopram,34,134,1992,1,1,2,1
Montgomery1992 (Study 89303 FDA),79,placebo,20,66,1992,1,0,2,1
Feighner1999 (Study 91206 FDA),80,citalopram,78,261,1999,1,1,2,0
Feighner1999 (Study 91206 FDA),80,placebo,41,129,1999,1,0,2,0
Andersen1986,81,citalopram,12,57,1986,0,3,2,0
Andersen1986,81,clomipramine,8,57,1986,0,3,2,0
Timmerman1993 (Study 89422 - FDA and Haffmans 1996),83,fluvoxamine,29,109,1993,1,0,1,0
Timmerman1993 (Study 89422 - FDA and Haffmans 1996),83,citalopram,22,108,1993,1,1,1,0
Patris1996 (Study 91301 - FDA),84,fluoxetine,21,184,1996,1,0,1,0
Patris1996 (Study 91301 - FDA),84,citalopram,24,173,1996,1,1,1,0
Bougerol1997 (Study 91302 - FDA),85,fluoxetine,45,158,1997,1,0,2,0
Bougerol1997 (Study 91302 - FDA),85,citalopram,48,158,1997,1,1,2,0
Stahl2000,88,sertraline,30,108,2000,0,3,2,0
Stahl2000,88,placebo,16,108,2000,0,0,2,0
Roose2004 (CIT-MD-03),89,citalopram,21,87,2001,1,1,2,0
Roose2004 (CIT-MD-03),89,placebo,12,91,2001,1,0,2,0
Gastpar2006,93,citalopram,6,127,2006,0,0,1,0
Gastpar2006,93,placebo,8,130,2006,0,0,1,0
Larsen1989,94,clomipramine,3,20,1989,0,3,2,0
Larsen1989,94,placebo,5,18,1989,0,0,2,0
"Liebowitz2008 (Study 332, NCT00277823)",95,desvenlafaxine,65,299,2008,1,1,1,0
"Liebowitz2008 (Study 332, NCT00277823)",95,placebo,25,152,2008,1,0,1,0
"Boyer2008 (Study 333, NCT00300378)(EUCTR2005-005463-28, 3151A1-333-EU)",96,desvenlafaxine,37,324,2004,1,1,1,0
"Boyer2008 (Study 333, NCT00300378)(EUCTR2005-005463-28, 3151A1-333-EU)",96,placebo,13,161,2004,1,0,1,0
"Lieberman2008a (Study 309)(EUCTR2004-000562-13, 3151A1-309-EU, NCT00090649)",97,placebo,13,120,2004,1,0,1,0
"Lieberman2008a (Study 309)(EUCTR2004-000562-13, 3151A1-309-EU, NCT00090649)",97,venlafaxine,16,127,2004,1,1,1,0
Lieberman2008b (Study 317),98,placebo,17,125,2004,1,0,1,0
Lieberman2008b (Study 317),98,venlafaxine,25,117,2004,1,1,1,0
Tourian2009 (NCT00384033),99,desvenlafaxine,101,315,2009,1,1,2,0
Tourian2009 (NCT00384033),99,duloxetine,46,159,2009,1,0,2,0
Tourian2009 (NCT00384033),99,placebo,45,164,2009,1,0,2,0
Dunlop2011 (NCT00824291),100,desvenlafaxine,60,291,2011,0,1,2,0
Dunlop2011 (NCT00824291),100,placebo,39,146,2011,0,0,2,0
Clayton2013 (NCT01121484),101,desvenlafaxine,33,218,2013,0,1,1,0
Clayton2013 (NCT01121484),101,placebo,43,221,2013,0,0,1,0
Iwata2013 (NCT00798707),102,desvenlafaxine,22,237,2013,0,1,1,0
Iwata2013 (NCT00798707),102,placebo,26,235,2013,0,0,1,0
Liebowitz2013 (NCT00863798),103,desvenlafaxine,25,227,2013,0,1,1,0
Liebowitz2013 (NCT00863798),103,placebo,32,227,2013,0,0,1,0
Clayton2015,104,placebo,37,306,2015,1,0,1,0
Clayton2015,104,desvenlafaxine,107,618,2015,1,1,1,0
"DeMartinis2007 (Study 306, NCT00072774)",105,placebo,22,120,2004,1,0,2,0
"DeMartinis2007 (Study 306, NCT00072774)",105,desvenlafaxine,27,118,2004,1,1,2,0
Goldstein2002 (HMAQ - Study Group A),106,duloxetine,24,70,2000,1,1,2,0
Goldstein2002 (HMAQ - Study Group A),106,placebo,24,70,2000,1,0,2,0
Goldstein2002 (HMAQ - Study Group A),106,fluoxetine,12,33,2000,1,0,2,0
Study F1J-MC-HMAQ - Study Group B (starting page in the pdf document: 147),107,duloxetine,25,82,2001,1,1,2,1
Study F1J-MC-HMAQ - Study Group B (starting page in the pdf document: 147),107,placebo,31,75,2001,1,0,2,1
Study F1J-MC-HMAQ - Study Group B (starting page in the pdf document: 147),107,fluoxetine,14,37,2001,1,0,2,1
"Goldstein2004a (HMAT - Study Group A, ID#4091)",108,duloxetine,58,175,2001,1,1,2,0
"Goldstein2004a (HMAT - Study Group A, ID#4091)",108,placebo,29,90,2001,1,0,2,0
"Goldstein2004a (HMAT - Study Group A, ID#4091)",108,paroxetine,31,89,2001,1,1,2,0
"Goldstein2004b (HMAT  - Study Group B, ID#4091)",109,duloxetine,69,177,2001,1,1,2,0
"Goldstein2004b (HMAT  - Study Group B, ID#4091)",109,placebo,37,89,2001,1,0,2,0
"Goldstein2004b (HMAT  - Study Group B, ID#4091)",109,paroxetine,38,87,2001,1,0,2,0
Detke2002a (HMBH -  Study Group A),110,duloxetine,43,123,2002,1,1,2,0
Detke2002a (HMBH -  Study Group A),110,placebo,36,122,2002,1,0,2,0
Detke2002b (HMBH - Study Group B),111,duloxetine,50,128,2002,1,1,2,0
Detke2002b (HMBH - Study Group B),111,placebo,49,139,2002,1,0,2,0
Detke2004 (HMAY Study Group A),112,duloxetine,21,188,2004,1,1,1,0
Detke2004 (HMAY Study Group A),112,paroxetine,10,86,2004,1,0,1,0
Detke2004 (HMAY Study Group A),112,placebo,18,93,2004,1,0,1,0
Perahia2008a (HMBU) (NCT00071695),113,duloxetine,35,166,2004,1,1,1,0
Perahia2008a (HMBU) (NCT00071695),113,venlafaxine,22,166,2004,1,0,1,0
Raskin2007 (HMBV) (NCT00062673),114,duloxetine,45,207,2004,1,1,2,0
Raskin2007 (HMBV) (NCT00062673),114,placebo,24,104,2004,1,0,2,0
Perahia2008b (HMCQ) (NCT00067912),115,duloxetine,44,164,2004,1,1,2,0
Perahia2008b (HMCQ) (NCT00067912),115,venlafaxine,68,340,2004,1,0,2,0
"Nierenberg2007 (F1J-MC-HMCR, NCT00073411, Pigott2007)",116,escitalopram,66,274,2005,1,0,1,0
"Nierenberg2007 (F1J-MC-HMCR, NCT00073411, Pigott2007)",116,duloxetine,85,273,2005,1,1,1,0
"Nierenberg2007 (F1J-MC-HMCR, NCT00073411, Pigott2007)",116,placebo,40,137,2005,1,0,1,0
Lee2007 (F1J-AA-HMCV) (NCT00489775),117,duloxetine,72,238,2005,1,1,2,0
Lee2007 (F1J-AA-HMCV) (NCT00489775),117,paroxetine,57,240,2005,1,0,2,0
Perahia2006 (HMAY - Study Group B),118,duloxetine,23,196,2006,1,1,2,0
Perahia2006 (HMAY - Study Group B),118,paroxetine,11,97,2006,1,0,1,0
Perahia2006 (HMAY - Study Group B),118,placebo,9,99,2006,1,0,1,0
Higuchi2009,119,duloxetine,21,150,2009,0,1,1,0
Higuchi2009,119,paroxetine,22,148,2009,0,0,1,0
Higuchi2009,119,placebo,15,146,2009,0,0,1,0
Cutler2009,120,duloxetine,46,151,2009,0,0,1,0
Cutler2009,120,placebo,33,157,2009,0,0,1,0
Robinson2014 (NCT00406848),121,duloxetine,70,249,2014,0,1,1,0
Robinson2014 (NCT00406848),121,placebo,43,121,2014,0,0,1,0
NCT01145755,124,duloxetine,28,47,2010,1,0,2,1
NCT01145755,124,placebo,25,44,2010,1,0,2,1
Hao2014,125,duloxetine,32,140,2012,0,1,2,0
Hao2014,125,paroxetine,36,141,2012,0,0,2,0
Burke2002 (SCT-MD-01),126,escitalopram,63,252,2000,1,1,2,0
Burke2002 (SCT-MD-01),126,citalopram,34,127,2000,1,1,2,0
Burke2002 (SCT-MD-01),126,placebo,36,127,2000,1,0,2,0
Gorman2002 (SCT-MD-02),127,escitalopram,33,129,2000,1,1,2,0
Gorman2002 (SCT-MD-02),127,citalopram,29,128,2000,1,1,2,0
Gorman2002 (SCT-MD-02),127,placebo,24,129,2000,1,0,2,0
Lepola2003 (ESC 99003),128,escitalopram,10,156,2000,1,1,1,0
Lepola2003 (ESC 99003),128,citalopram,9,161,2000,1,0,1,0
Lepola2003 (ESC 99003),128,placebo,15,154,2000,1,0,1,0
SCT-MD-09,129,escitalopram,1,16,2001,1,1,2,1
SCT-MD-09,129,fluoxetine,2,14,2001,1,0,2,1
Kennedy2005 (SCT-MD-16),130,escitalopram,36,102,2001,1,1,2,1
Kennedy2005 (SCT-MD-16),130,fluoxetine,26,103,2001,1,0,2,1
Ninan2003 (poster SCT-MD-26),131,escitalopram,38,154,2002,1,1,2,1
Ninan2003 (poster SCT-MD-26),131,placebo,24,155,2002,1,0,2,1
Bielski2004 (SCT-MD-12),132,escitalopram,29,101,2002,1,1,1,0
Bielski2004 (SCT-MD-12),132,venlafaxine,35,101,2002,1,0,1,0
Montgomery2004a (Study 99067),133,escitalopram,23,148,2002,1,1,1,0
Montgomery2004a (Study 99067),133,venlafaxine,21,145,2002,1,0,1,0
Wade2002 (ESC Study 99001 - FDA),134,placebo,29,189,2002,1,0,1,0
Wade2002 (ESC Study 99001 - FDA),134,escitalopram,31,191,2002,1,1,1,0
Ventura2007 (SCT-MD-18),135,escitalopram,19,107,2003,1,1,1,0
Ventura2007 (SCT-MD-18),135,sertraline,15,108,2003,1,0,1,0
Lalit2004,136,escitalopram,4,69,2004,0,1,2,0
Lalit2004,136,citalopram,3,74,2004,0,1,2,0
Lalit2004,136,sertraline,9,71,2004,0,0,2,0
Bose2008 (SCT-MD-13),137,escitalopram,36,132,2004,1,1,2,1
Bose2008 (SCT-MD-13),137,placebo,26,135,2004,1,0,2,1
Alexopoulos2004 (poster SCT-MD-27),138,escitalopram,28,136,2004,1,1,2,0
Alexopoulos2004 (poster SCT-MD-27),138,sertraline,25,138,2004,1,0,2,0
Alexopoulos2004 (poster SCT-MD-27),138,placebo,30,135,2004,1,0,2,0
Colonna2005 (Study 99022),139,escitalopram,25,175,2005,1,1,1,0
Colonna2005 (Study 99022),139,citalopram,30,182,2005,1,0,1,0
Moore2005,140,escitalopram,10,142,2005,0,1,1,0
Moore2005,140,citalopram,25,152,2005,0,0,1,0
Kasper2005a (Study 99024),141,escitalopram,30,174,2005,1,1,2,0
Kasper2005a (Study 99024),141,fluoxetine,42,164,2005,1,0,2,0
Kasper2005a (Study 99024),141,placebo,20,180,2005,1,0,2,0
Baldwin2006b (Study 99505),142,paroxetine,14,159,2006,1,0,1,0
Baldwin2006b (Study 99505),142,escitalopram,15,166,2006,1,1,1,0
Wade2007 (Study 10990),143,escitalopram,31,144,2006,1,1,1,0
Wade2007 (Study 10990),143,duloxetine,37,151,2006,1,0,1,0
Khan2007 (SCT-MD-23) (NCT00108979),144,escitalopram,21,140,2006,1,1,2,0
Khan2007 (SCT-MD-23) (NCT00108979),144,duloxetine,46,138,2006,1,0,2,0
Boulenger2006 (Study 10351),145,escitalopram,22,232,2006,1,1,2,0
Boulenger2006 (Study 10351),145,paroxetine,34,227,2006,1,1,2,0
Yevtushenko2007,147,escitalopram,1,109,2007,0,1,1,0
Yevtushenko2007,147,citalopram,2,110,2007,0,0,1,0
Mao2008,148,fluoxetine,17,117,2008,0,0,1,0
Mao2008,148,escitalopram,15,123,2008,0,1,1,0
Jiang2009,150,escitalopram,1,32,2009,0,3,1,0
Jiang2009,150,citalopram,2,32,2009,0,3,1,0
Ou2010,151,citalopram,18,120,2010,0,3,1,0
Ou2010,151,escitalopram,19,120,2010,0,3,1,0
Li2010,152,escitalopram,2,24,2010,0,1,2,0
Li2010,152,citalopram,3,24,2010,0,1,2,0
Hirayasu2011a,153,escitalopram,36,205,2011,0,1,1,0
Hirayasu2011a,153,placebo,19,105,2011,0,0,1,0
Hirayasu2011b,154,placebo,21,124,2011,0,0,1,0
Hirayasu2011b,154,escitalopram,32,240,2011,0,1,1,0
Hirayasu2011b,154,paroxetine,13,121,2011,0,0,1,0
Dube2010 (NCT00420004),155,escitalopram,31,62,2008,0,0,2,0
Dube2010 (NCT00420004),155,placebo,68,138,2008,0,0,2,0
Kasper2012 (NCT00807248),157,escitalopram,12,140,2008,0,1,2,0
Kasper2012 (NCT00807248),157,placebo,21,71,2008,0,0,2,0
"Wang 2014 (EUCTR2005-005052-40, NCT00351169, D1448C00004)",158,escitalopram,39,157,2007,0,0,1,0
"Wang 2014 (EUCTR2005-005052-40, NCT00351169, D1448C00004)",158,placebo,40,157,2007,0,0,1,0
Griebel2012 (Study DF15878) (NCT00358631),160,escitalopram,24,84,2007,0,0,2,0
Griebel2012 (Study DF15878) (NCT00358631),160,placebo,26,76,2007,0,0,2,0
NCT01020799,161,escitalopram,7,50,2009,1,0,1,1
NCT01020799,161,placebo,14,99,2009,1,0,1,1
SCT-MD-49 (NCT00668525),162,escitalopram,77,325,2009,1,1,2,1
SCT-MD-49 (NCT00668525),162,placebo,53,220,2009,1,0,1,1
Mischoulon2014 (NCT00101452),163,escitalopram,35,69,2009,1,0,2,0
Mischoulon2014 (NCT00101452),163,placebo,29,65,2009,1,0,2,0
Study 19 (FDA) (Fabre1985),164,fluoxetine,11,22,1985,1,1,2,1
Study 19 (FDA) (Fabre1985),164,placebo,12,25,1985,1,0,2,1
Study 25 (FDA) (Rickels1986),165,fluoxetine,8,18,1986,1,1,2,1
Study 25 (FDA) (Rickels1986),165,placebo,10,24,1986,1,0,2,1
Study 62a (FDA) - MILD depression (Dunlop1990),166,fluoxetine,131,316,1990,1,1,2,1
Study 62a (FDA) - MILD depression (Dunlop1990),166,placebo,19,56,1990,1,0,2,1
Study 62b (FDA) - MODERATE depression,167,fluoxetine,137,308,1987,1,1,2,1
Study 62b (FDA) - MODERATE depression,167,placebo,21,48,1987,1,0,2,1
Chouinard1985,168,fluoxetine,4,25,1985,0,3,2,0
Chouinard1985,168,amitriptyline,6,28,1985,0,3,2,0
Cohn1985a,169,fluoxetine,19,54,1985,0,1,2,0
Cohn1985a,169,placebo,42,58,1985,0,0,2,0
Stark1985 (Study 27 - FDA),171,fluoxetine,87,185,1985,1,1,2,0
Stark1985 (Study 27 - FDA),171,placebo,95,169,1985,1,0,2,0
Young1987  ,172,fluoxetine,7,32,1987,0,3,2,0
Young1987  ,172,amitriptyline,7,32,1987,0,3,2,0
Byerley1988,173,placebo,13,29,1988,0,0,1,0
Byerley1988,173,fluoxetine,12,32,1988,0,1,1,0
DeRonchi1998,174,fluoxetine,9,32,1988,0,3,2,0
DeRonchi1998,174,amitriptyline,11,33,1988,0,3,2,0
Debus1988,175,fluoxetine,8,22,1988,0,1,2,0
Debus1988,175,trazodone,10,21,1988,0,0,2,0
Upward1988,176,fluoxetine,2,13,1988,0,1,2,0
Upward1988,176,amitriptyline,2,14,1988,0,0,2,0
Feighner1989a,178,placebo,40,59,1989,0,0,2,0
Feighner1989a,178,fluoxetine,31,62,1989,0,3,2,0
Falk1989,179,trazodone,10,13,1989,0,0,2,0
Falk1989,179,fluoxetine,4,14,1989,0,1,2,0
Fawcett1989,180,amitriptyline,11,20,1989,0,0,2,0
Fawcett1989,180,fluoxetine,8,20,1989,0,1,2,0
Ropert1989  ,183,fluoxetine,16,71,1989,0,3,2,0
Ropert1989  ,183,clomipramine,24,72,1989,0,0,2,0
Fudge1990,184,fluoxetine,5,21,1990,0,3,2,0
Fudge1990,184,trazodone,2,17,1990,0,3,2,0
Kerkhofs1990,185,fluoxetine,7,16,1990,0,1,2,0
Kerkhofs1990,185,amitriptyline,8,18,1990,0,0,2,0
Noguera1991,186,clomipramine,16,60,1991,0,0,2,0
Noguera1991,186,fluoxetine,13,60,1991,0,1,2,0
Keegan1991,187,fluoxetine,2,20,1991,0,1,1,0
Keegan1991,187,amitriptyline,3,22,1991,0,0,1,0
Preskorn1991,188,fluoxetine,6,30,1991,0,1,2,0
Preskorn1991,188,amitriptyline,16,31,1991,0,0,2,0
Beasley1991,189,trazodone,23,61,1991,0,0,2,0
Beasley1991,189,fluoxetine,20,65,1991,0,1,2,0
Judd1993,190,fluoxetine,7,30,1993,0,1,2,0
Judd1993,190,amitriptyline,5,28,1993,0,0,2,0
Heiligenstein1994,191,fluoxetine,14,46,1994,0,1,1,0
Heiligenstein1994,191,placebo,10,43,1994,0,0,1,0
Tollefson1995,193,fluoxetine,72,335,1995,0,1,2,0
Tollefson1995,193,placebo,65,336,1995,0,0,2,0
Sramek1995,194,fluoxetine,12,72,1995,0,0,1,0
Sramek1995,194,placebo,9,72,1995,0,0,1,0
Demyttenaere1998  ,195,amitriptyline,14,31,1998,0,0,2,0
Demyttenaere1998  ,195,fluoxetine,6,35,1998,0,1,2,0
Marchesi1998  ,196,fluoxetine,7,67,1998,0,1,1,0
Marchesi1998  ,196,amitriptyline,10,75,1998,0,0,1,0
OntiverosSanchez1998  ,197,fluoxetine,7,21,1998,0,1,2,0
OntiverosSanchez1998  ,197,amitriptyline,10,21,1998,0,0,2,0
Versiani1999,198,fluoxetine,12,77,1999,0,1,1,0
Versiani1999,198,amitriptyline,15,80,1999,0,0,1,0
Corrigan2000  ,199,fluoxetine,5,35,2000,0,0,2,0
Corrigan2000  ,199,placebo,12,35,2000,0,0,2,0
McGrath2000,200,fluoxetine,14,49,2000,0,1,2,0
McGrath2000,200,placebo,23,52,2000,0,0,2,0
Fava2002,201,sertraline,26,96,2002,0,0,2,0
Fava2002,201,fluoxetine,24,92,2002,0,1,2,0
Fava2002,201,paroxetine,27,96,2002,0,0,2,0
NCT01808612,205,fluoxetine,22,253,2013,1,1,1,1
NCT01808612,205,placebo,14,260,2013,1,0,1,1
Fava2005,206,placebo,22,43,2005,0,0,2,0
Fava2005,206,fluoxetine,23,47,2005,0,0,2,0
Bjerkenstedt2005  ,207,fluoxetine,9,57,2005,0,0,1,0
Bjerkenstedt2005  ,207,placebo,6,58,2005,0,0,1,0
DeWilde1983a,209,fluvoxamine,0,22,1983,0,1,1,0
DeWilde1983a,209,clomipramine,0,21,1983,0,0,1,0
Itil1983,210,fluvoxamine,12,22,1983,0,1,2,0
Itil1983,210,placebo,11,22,1983,0,0,2,0
Norton1984,212,fluvoxamine,4,35,1984,0,1,1,0
Norton1984,212,placebo,3,25,1984,0,0,1,0
Dominguez1985,213,fluvoxamine,19,35,1985,1,3,2,0
Dominguez1985,213,placebo,10,31,1985,1,0,2,0
Cassano1986,214,fluvoxamine,59,161,1986,0,1,2,0
Cassano1986,214,placebo,49,149,1986,0,0,2,0
Lapierre1987,216,fluvoxamine,7,22,1987,0,1,2,0
Lapierre1987,216,placebo,13,20,1987,0,0,2,0
March1990,219,fluvoxamine,5,18,1990,0,1,1,0
March1990,219,placebo,6,18,1990,0,0,1,0
Remick1994,220,amitriptyline,8,17,1994,0,0,2,0
Remick1994,220,fluvoxamine,3,16,1994,0,1,2,0
Nemeroff1995,221,fluvoxamine,18,49,1995,0,1,2,0
Nemeroff1995,221,sertraline,7,48,1995,0,0,2,0
Ottevanger1995,222,fluvoxamine,5,20,1995,0,1,1,0
Ottevanger1995,222,clomipramine,3,20,1995,0,0,1,0
Rapaport1996,223,fluvoxamine,7,51,1996,0,1,1,0
Rapaport1996,223,fluoxetine,8,49,1996,0,0,1,0
Claghorn1996,224,fluvoxamine,30,50,1996,0,1,2,0
Claghorn1996,224,placebo,30,50,1996,0,0,2,0
Fabre1996,225,fluvoxamine,28,50,1996,0,1,1,0
Fabre1996,225,placebo,31,50,1996,0,0,1,0
Kiev1997,226,fluvoxamine,11,30,1997,0,1,2,0
Kiev1997,226,paroxetine,9,30,1997,0,0,2,0
Murasaki1998,227,fluvoxamine,43,113,1998,0,1,1,0
Murasaki1998,227,amitriptyline,56,122,1998,0,0,1,0
Dalery2003,228,fluvoxamine,24,90,2003,0,1,2,0
Dalery2003,228,fluoxetine,20,94,2003,0,0,2,0
Rossini2005,229,fluvoxamine,1,40,2005,0,3,1,0
Rossini2005,229,sertraline,3,48,2005,0,3,1,0
Harris1991,230,fluvoxamine,11,35,1991,0,3,2,0
Harris1991,230,amitriptyline,8,34,1991,0,3,2,0
Roth1990,231,fluvoxamine,6,30,1990,0,1,2,0
Roth1990,231,placebo,4,30,1990,0,0,2,0
Walczak1996,232,fluvoxamine,131,300,1996,0,1,2,0
Walczak1996,232,placebo,77,200,1996,0,0,2,0
"Montgomery2013 (F02695LP202, EudraCT2006-002404-34)",233,placebo,70,281,2007,1,0,1,0
"Montgomery2013 (F02695LP202, EudraCT2006-002404-34)",233,levomilnacipran,57,282,2007,1,1,1,0
"Gommoll2014 (LVM-MD-02, NCT00969150)",234,placebo,33,182,2010,1,0,1,0
"Gommoll2014 (LVM-MD-02, NCT00969150)",234,levomilnacipran,40,175,2010,1,1,1,0
"Asnis2013 (LVM-MD-01, NCT00969709)",235,placebo,41,179,2011,1,0,2,0
"Asnis2013 (LVM-MD-01, NCT00969709)",235,levomilnacipran,177,545,2011,1,1,2,0
"Sambunaris2014 (LVM-MD-03, NCT01034462)",236,placebo,48,220,2011,1,0,1,0
"Sambunaris2014 (LVM-MD-03, NCT01034462)",236,levomilnacipran,59,222,2011,1,1,1,0
"Bakish2014 (LVM-MD-10, NCT01377194)",237,placebo,35,189,2012,1,0,1,0
"Bakish2014 (LVM-MD-10, NCT01377194)",237,levomilnacipran,92,379,2012,1,1,1,0
NCT01254305,238,placebo,22,93,2012,1,0,2,1
NCT01254305,238,levomilnacipran,18,90,2012,1,1,2,1
Ansseau1989a,239,milnacipran,24,95,1989,0,3,2,0
Ansseau1989a,239,amitriptyline,11,49,1989,0,0,2,0
Ansseau1989b,240,milnacipran,3,44,1989,0,3,1,0
Ansseau1989b,240,amitriptyline,5,43,1989,0,0,1,0
Ansseau1991,241,fluvoxamine,6,41,1991,0,3,2,0
Ansseau1991,241,milnacipran,9,85,1991,0,3,2,0
Ansseau1994b,242,milnacipran,23,97,1994,0,1,1,0
Ansseau1994b,242,fluoxetine,18,93,1994,0,0,1,0
Guelfi1998,244,milnacipran,99,200,1998,0,1,1,0
Guelfi1998,244,fluoxetine,50,100,1998,0,0,1,0
Clerc2001,245,fluvoxamine,17,56,2001,0,0,2,0
Clerc2001,245,milnacipran,15,57,2001,0,1,2,0
Yang2003,246,milnacipran,15,27,2003,0,1,2,0
Yang2003,246,sertraline,11,26,2003,0,0,2,0
Sechter2004,247,milnacipran,29,149,2004,0,1,2,0
Sechter2004,247,paroxetine,33,153,2004,0,0,2,0
Kamijima2013 (japicCTI-090733),248,milnacipran,117,604,2013,0,1,1,0
Kamijima2013 (japicCTI-090733),248,paroxetine,56,301,2013,0,0,1,0
MIR 003-003 (FDA),249,mirtazapine,17,45,1996,1,1,2,1
MIR 003-003 (FDA),249,placebo,19,45,1996,1,0,2,1
MIR 003-020 (FDA),250,mirtazapine,15,44,1996,1,1,2,1
MIR 003-020 (FDA),250,amitriptyline,18,43,1996,1,0,2,1
MIR 003-020 (FDA),250,placebo,17,43,1996,1,0,2,1
MIR 003-021 (FDA),251,mirtazapine,24,50,1996,1,1,2,1
MIR 003-021 (FDA),251,amitriptyline,18,50,1996,1,0,2,1
MIR 003-021 (FDA),251,placebo,27,50,1996,1,0,2,1
Vartiainen1994 (MIR 84023 FDA),252,mirtazapine,23,60,1994,1,1,2,0
Vartiainen1994 (MIR 84023 FDA),252,placebo,26,57,1994,1,0,2,0
Smith1990 (MIR 003-024 FDA),254,mirtazapine,20,50,1990,1,1,2,0
Smith1990 (MIR 003-024 FDA),254,amitriptyline,15,50,1990,1,0,2,0
Smith1990 (MIR 003-024 FDA),254,placebo,23,50,1990,1,0,2,0
Bremner1995(MIR 003-022 - FDA),255,amitriptyline,10,50,1995,1,0,2,0
Bremner1995(MIR 003-022 - FDA),255,placebo,12,50,1995,1,0,2,0
Bremner1995(MIR 003-022 - FDA),255,mirtazapine,9,50,1995,1,1,2,0
Claghorn1995 (MIR 003-002 (FDA),256,mirtazapine,16,45,1995,1,1,2,0
Claghorn1995 (MIR 003-002 (FDA),256,placebo,25,45,1995,1,0,2,0
Halikas1995 (MIR 003-023 - FDA),257,mirtazapine,11,50,1995,1,1,2,0
Halikas1995 (MIR 003-023 - FDA),257,trazodone,16,50,1995,1,0,2,0
Halikas1995 (MIR 003-023 - FDA),257,placebo,14,50,1995,1,0,2,0
vanMoffaert1995b,258,mirtazapine,26,100,1995,0,1,2,0
vanMoffaert1995b,258,trazodone,23,100,1995,0,0,2,0
Wheatley1998,262,mirtazapine,17,66,1996,0,1,1,0
Wheatley1998,262,fluoxetine,21,67,1996,0,0,1,0
Leinonen1999 (Agren1995),263,mirtazapine,18,137,1999,0,1,1,0
Leinonen1999 (Agren1995),263,citalopram,8,133,1999,0,0,1,0
Benkert2000 (E-1559),264,mirtazapine,30,139,2000,1,1,2,0
Benkert2000 (E-1559),264,paroxetine,33,136,2000,1,0,2,0
Schatzberg2002 (003-901),265,mirtazapine,29,128,2002,1,1,1,0
Schatzberg2002 (003-901),265,paroxetine,39,126,2002,1,0,1,0
Hong2003 (22521),266,mirtazapine,30,66,2000,1,1,2,0
Hong2003 (22521),266,fluoxetine,22,66,2000,1,0,2,0
"Behnke2003 (E-1690, Kjernisted2002)",267,mirtazapine,41,176,2003,1,1,2,0
"Behnke2003 (E-1690, Kjernisted2002)",267,sertraline,32,170,2003,1,0,2,0
Wade2003 (E-1721),268,mirtazapine,40,99,2003,1,1,1,0
Wade2003 (E-1721),268,paroxetine,39,98,2003,1,0,1,0
Winokur2003,269,mirtazapine,0,8,2003,0,1,1,0
Winokur2003,269,fluoxetine,1,12,2003,0,0,1,0
Amini2005,270,mirtazapine,2,18,2005,0,0,1,0
Amini2005,270,fluoxetine,3,18,2005,0,0,1,0
Versiani2005,271,mirtazapine,14,145,2005,0,1,1,0
Versiani2005,271,fluoxetine,18,149,2005,0,0,1,0
Szegedi2006,272,mirtazapine,39,130,2006,0,1,1,0
Szegedi2006,272,venlafaxine,47,128,2006,0,0,1,0
Kinoshita2009,273,mirtazapine,49,211,2009,0,1,1,0
Kinoshita2009,273,placebo,15,70,2009,0,0,1,0
003-048,274,mirtazapine,75,210,2001,1,1,2,1
003-048,274,fluoxetine,42,210,2001,1,0,2,1
003-048,274,placebo,21,72,2001,1,0,2,1
003-008 (FDA),275,mirtazapine,33,60,1990,1,1,2,1
003-008 (FDA),275,placebo,12,30,1990,1,0,2,1
003-042,276,mirtazapine,71,210,1998,1,1,2,1
003-042,276,placebo,22,70,1998,1,0,2,1
"Murasaki2010a (iQWIG22532, Schoemaker2002)",277,mirtazapine,22,104,2000,1,1,1,0
"Murasaki2010a (iQWIG22532, Schoemaker2002)",277,fluvoxamine,19,105,2000,1,0,1,0
"Murasaki2010b (iQWIG9902, Schoemaker2002)",278,mirtazapine,24,101,2002,1,1,1,0
"Murasaki2010b (iQWIG9902, Schoemaker2002)",278,fluvoxamine,22,102,2002,1,0,1,0
Benkert2006(C-1763),279,mirtazapine,39,140,2003,1,1,1,0
Benkert2006(C-1763),279,venlafaxine,47,135,2003,1,0,1,0
E-1569,280,mirtazapine,9,73,1996,1,1,1,1
E-1569,280,paroxetine,7,75,1996,1,0,1,1
"Debonnel2000 (Blier2009, iQWIG E-1639)",281,mirtazapine,0,21,2000,1,1,2,0
"Debonnel2000 (Blier2009, iQWIG E-1639)",281,paroxetine,3,21,2000,1,0,2,0
Armitage1997,284,nefazodone,5,22,1997,0,1,2,0
Armitage1997,284,fluoxetine,5,21,1997,0,0,2,0
Baldwin1996,285,nefazodone,28,105,1996,0,1,2,0
Baldwin1996,285,paroxetine,28,101,1996,0,0,2,0
Berlanga1997,286,nefazodone,8,37,1997,0,1,2,0
Berlanga1997,286,fluoxetine,2,37,1997,0,0,2,0
D'Amico1990 (FDA 030-A2-0007),288,nefazodone,18,47,1990,1,1,2,0
D'Amico1990 (FDA 030-A2-0007),288,placebo,15,47,1990,1,0,2,0
Feiger1996,289,nefazodone,19,78,1996,0,1,2,0
Feiger1996,289,sertraline,20,82,1996,0,0,2,0
Feighner1998,290,nefazodone,30,61,1998,0,1,2,0
Feighner1998,290,placebo,33,59,1998,0,0,2,0
Fontaine1994 (FDA 03A0A-003),291,nefazodone,11,44,1994,1,1,2,0
Fontaine1994 (FDA 03A0A-003),291,placebo,21,45,1994,1,0,2,0
Gillin1997,292,nefazodone,5,24,1997,0,1,1,0
Gillin1997,292,fluoxetine,3,20,1997,0,0,1,0
Hicks2002,293,nefazodone,5,20,2002,0,1,1,0
Hicks2002,293,paroxetine,3,20,2002,0,0,1,0
Mendels1995 (FDA 03A0A-004B),294,nefazodone,17,80,1995,1,1,2,0
Mendels1995 (FDA 03A0A-004B),294,placebo,22,80,1995,1,0,2,0
Rickels1994 ( FDA CN104-005),295,nefazodone,29,96,1994,1,1,2,0
Rickels1994 ( FDA CN104-005),295,placebo,36,95,1994,1,0,2,0
Rickels1995 (FDA CN104-006-1),296,nefazodone,30,45,1995,1,1,2,0
Rickels1995 (FDA CN104-006-1),296,placebo,26,44,1995,1,0,2,0
Cohn1996 (FDA CN104-006-2),297,nefazodone,15,43,1996,1,1,2,0
Cohn1996 (FDA CN104-006-2),297,placebo,12,43,1996,1,0,2,0
03A0A-004A (FDA),300,nefazodone,29,80,1994,1,1,2,1
03A0A-004A (FDA),300,placebo,32,80,1994,1,0,2,1
PAR 29060.308 (HP/81/74A),304,paroxetine,1,10,1983,1,1,1,1
PAR 29060.308 (HP/81/74A),304,amitriptyline,2,12,1983,1,0,1,1
PAR 29060.318 (HP/82/64A),305,paroxetine,1,9,1983,1,1,1,1
PAR 29060.318 (HP/82/64A),305,amitriptyline,2,12,1983,1,0,1,1
Battegay1985 (PAR 29060.309 HP/81/162A),306,paroxetine,3,11,1984,1,1,2,0
Battegay1985 (PAR 29060.309 HP/81/162A),306,amitriptyline,8,10,1984,1,0,2,0
PAR 29060.310 (HP 81/85A),307,paroxetine,4,10,1984,1,1,2,1
PAR 29060.310 (HP 81/85A),307,amitriptyline,5,13,1984,1,0,2,1
PAR 29060.316 (HP/82/47A),308,paroxetine,3,9,1984,1,1,2,1
PAR 29060.316 (HP/82/47A),308,amitriptyline,3,8,1984,1,0,2,1
PAR 01 001 (GSK & FDA),309,paroxetine,8,25,1985,1,1,2,0
PAR 01 001 (GSK & FDA),309,placebo,10,25,1985,1,0,2,0
PAR 29060.314 (HP 82/134),310,paroxetine,7,10,1985,1,1,2,1
PAR 29060.314 (HP 82/134),310,amitriptyline,4,8,1985,1,0,2,1
PAR 29060/281 ,311,paroxetine,36,82,1985,1,1,2,1
PAR 29060/281 ,311,amitriptyline,26,80,1985,1,0,2,1
PAR MDUK 032,312,paroxetine,10,29,1986,1,1,2,1
PAR MDUK 032,312,amitriptyline,10,30,1986,1,0,2,1
PAR 279 MDUK,313,paroxetine,7,19,1986,1,1,2,1
PAR 279 MDUK,313,placebo,4,10,1986,1,0,2,1
"Dunbar1993a (Claghorn1992, Rickels1989, Rickels1992, PAR 02-001 - FDA)",314,paroxetine,22,55,1986,1,1,2,0
"Dunbar1993a (Claghorn1992, Rickels1989, Rickels1992, PAR 02-001 - FDA)",314,placebo,25,56,1986,1,0,2,0
"Dunbar1993b  (Claghorn1992, PAR 02-002 - FDA)",315,paroxetine,15,36,1986,1,1,2,0
"Dunbar1993b  (Claghorn1992, PAR 02-002 - FDA)",315,placebo,18,36,1986,1,0,2,0
"Dunbar1993c  (Smith1992, PAR 02-003 - FDA)",316,paroxetine,18,39,1986,1,1,2,0
"Dunbar1993c  (Smith1992, PAR 02-003 - FDA)",316,placebo,24,38,1986,1,0,2,0
Feighner1993a (Feighner 1989c PAR 03 001 - FDA),317,paroxetine,19,40,1986,1,1,2,0
Feighner1993a (Feighner 1989c PAR 03 001 - FDA),317,placebo,22,40,1986,1,0,2,0
Feighner1993b (Cohn1990 Cohn1992 PAR 03 002 - FDA),318,paroxetine,21,40,1986,1,1,2,0
Feighner1993b (Cohn1990 Cohn1992 PAR 03 002 - FDA),318,placebo,28,40,1986,1,0,2,0
Feighner1993c (PAR 03 003 - FDA),319,paroxetine,22,41,1986,1,1,2,0
Feighner1993c (PAR 03 003 - FDA),319,placebo,22,42,1986,1,0,2,0
Feighner1993d (Shrivastava1992 PAR 03 004 - FDA),320,paroxetine,14,40,1986,1,1,2,0
Feighner1993d (Shrivastava1992 PAR 03 004 - FDA),320,placebo,22,40,1986,1,0,2,0
Feighner1993e (Peselow1989 PAR 03 005 - FDA),321,paroxetine,11,40,1986,1,1,2,0
Feighner1993e (Peselow1989 PAR 03 005 - FDA),321,placebo,11,42,1986,1,0,2,0
Feighner1993f (Fabre1992 PAR 03 006 - FDA),322,paroxetine,24,40,1986,1,1,2,0
Feighner1993f (Fabre1992 PAR 03 006 - FDA),322,placebo,33,40,1986,1,0,2,0
29060 07 001,323,paroxetine,5,13,1987,1,1,2,1
29060 07 001,323,placebo,5,12,1987,1,0,2,1
"Dunbar1993d (Kiev1992, PAR 02-004 - FDA)",325,paroxetine,19,40,1987,1,1,2,0
"Dunbar1993d (Kiev1992, PAR 02-004 - FDA)",325,placebo,23,41,1987,1,0,2,0
Guillibert1989 (PAR 290 MDF 29060 1727 M),326,clomipramine,12,39,1988,1,0,2,0
Guillibert1989 (PAR 290 MDF 29060 1727 M),326,paroxetine,9,40,1988,1,1,2,0
Pelicier1993 (PAR MDED/29060/III/86/1728M291),327,clomipramine,10,42,1988,1,0,2,0
Pelicier1993 (PAR MDED/29060/III/86/1728M291),327,paroxetine,12,41,1988,1,1,2,0
Miller1989 (MDUK/29060/III/82/006 (PAR-274) PAR UK 06 - FDA),328,paroxetine,10,22,1988,1,1,2,0
Miller1989 (MDUK/29060/III/82/006 (PAR-274) PAR UK 06 - FDA),328,placebo,5,25,1988,1,0,2,0
MDF/29060/III/070/88/MC,329,paroxetine,3,32,1989,1,1,2,1
MDF/29060/III/070/88/MC,329,clomipramine,6,30,1989,1,0,2,1
"Rouillon1991 (Limosin2006, 029060/1/CPMS 069 1991)",330,paroxetine,10,45,1989,1,1,2,0
"Rouillon1991 (Limosin2006, 029060/1/CPMS 069 1991)",330,clomipramine,15,47,1989,1,0,2,0
Geretsegger1995 (MY-060/BRL-029060/1),331,paroxetine,10,44,1990,1,1,2,0
Geretsegger1995 (MY-060/BRL-029060/1),331,amitriptyline,12,47,1990,1,0,2,0
DUAG1990,332,paroxetine,12,62,1990,0,3,2,0
DUAG1990,332,clomipramine,19,58,1990,0,3,2,0
MY-1045/BRL-029060/1 (PAR 128),333,paroxetine,137,357,1991,1,1,2,1
MY-1045/BRL-029060/1 (PAR 128),333,fluoxetine,114,351,1991,1,0,2,1
MY-1045/BRL-029060/1 (PAR 128),333,placebo,62,140,1991,1,0,2,1
MY-1043/BRL-029060/115,334,paroxetine,109,284,1991,1,1,2,1
MY-1043/BRL-029060/115,334,fluoxetine,108,289,1991,1,0,2,1
MY-1043/BRL-029060/115,334,placebo,44,118,1991,1,0,2,1
Tignol1993 (29060/087),335,paroxetine,25,89,1991,1,1,1,0
Tignol1993 (29060/087),335,fluoxetine,33,87,1991,1,0,1,0
Schoene1993 (Geretsegger1994 MY1021/BRC),336,paroxetine,9,54,1991,1,1,1,0
Schoene1993 (Geretsegger1994 MY1021/BRC),336,fluoxetine,9,52,1991,1,0,1,0
Ontiveros1994 (MY-0144/BRL 29060/1/CPMS-135 (PAR135)),337,paroxetine,7,60,1992,1,0,1,0
Ontiveros1994 (MY-0144/BRL 29060/1/CPMS-135 (PAR135)),337,fluoxetine,9,62,1992,1,0,1,0
Bignamini1992 (PAR 29060/078),338,paroxetine,31,156,1992,1,1,1,0
Bignamini1992 (PAR 29060/078),338,amitriptyline,20,153,1992,1,0,1,0
Hutchinson1992,339,amitriptyline,11,32,1992,0,0,2,0
Hutchinson1992,339,paroxetine,12,58,1992,0,1,2,0
Staner1995 (063),340,paroxetine,5,21,1992,1,1,2,0
Staner1995 (063),340,amitriptyline,4,19,1992,1,0,2,0
Dunner1992 (PAR 29060.09),341,paroxetine,126,316,1992,1,1,2,0
Dunner1992 (PAR 29060.09),341,placebo,19,53,1992,1,0,2,0
Ansseau1994a (MY-1005/BRL-029060/1/CPMS-112),342,paroxetine,16,55,1992,1,1,2,0
Ansseau1994a (MY-1005/BRL-029060/1/CPMS-112),342,fluvoxamine,23,65,1992,1,0,2,0
DeWilde1993,343,paroxetine,14,49,1993,0,1,1,0
DeWilde1993,343,fluoxetine,15,50,1993,0,0,1,0
Gagiano1993,344,paroxetine,8,45,1993,0,1,1,0
Gagiano1993,344,fluoxetine,10,45,1993,0,0,1,0
MY-1042/BRL-029060/CPMS-251,345,paroxetine,45,125,1993,1,1,2,1
MY-1042/BRL-029060/CPMS-251,345,placebo,41,129,1993,1,0,2,1
Edwards1989 (MD/PAR/009 PAR-276),346,paroxetine,10,21,1989,1,1,2,0
Edwards1989 (MD/PAR/009 PAR-276),346,placebo,14,21,1989,1,0,2,0
29060/356,347,paroxetine,21,68,1994,1,1,2,1
29060/356,347,fluoxetine,27,70,1994,1,0,2,1
SER-CHN-1,348,paroxetine,2,113,1994,1,1,1,1
SER-CHN-1,348,amitriptyline,7,118,1994,1,0,1,1
"Moller1993 (Stuppaeck1994, MY-059.073/29060/1)",350,paroxetine,34,78,1989,1,1,2,0
"Moller1993 (Stuppaeck1994, MY-059.073/29060/1)",350,amitriptyline,30,75,1989,1,0,2,0
Christiansen1996,351,paroxetine,15,71,1996,0,3,2,0
Christiansen1996,351,amitriptyline,16,73,1996,0,3,2,0
Golden2002a (29060/448),352,paroxetine,70,212,1997,1,1,2,0
Golden2002a (29060/448),352,placebo,29,103,1997,1,0,2,0
Golden2002b (29060/449),353,paroxetine,64,220,1997,1,1,2,0
Golden2002b (29060/449),353,placebo,33,110,1997,1,0,2,0
Rapaport2003 (PAR487),354,paroxetine,53,210,1997,1,1,2,0
Rapaport2003 (PAR487),354,placebo,25,109,1997,1,0,2,0
Ravindran1997 (MY-1055/BRL-029060/1/CPMS-245 PAR 245),356,paroxetine,103,513,1994,1,1,2,0
Ravindran1997 (MY-1055/BRL-029060/1/CPMS-245 PAR 245),356,clomipramine,142,506,1994,1,0,2,0
Fava1998,357,paroxetine,16,55,1998,0,1,2,0
Fava1998,357,fluoxetine,16,54,1998,0,0,2,0
Fava1998,357,placebo,4,19,1998,0,0,2,0
Chouinard1999 (29060/131),359,paroxetine,40,102,1999,1,1,1,0
Chouinard1999 (29060/131),359,fluoxetine,33,101,1999,1,0,1,0
Tsutsui2000,360,paroxetine,41,116,2000,0,1,1,0
Tsutsui2000,360,trazodone,44,109,2000,0,0,1,0
Miura2000,361,paroxetine,53,109,2000,0,1,1,0
Miura2000,361,amitriptyline,59,119,2000,0,0,1,0
Jefferson2000 (29060/785),362,placebo,18,105,2001,1,0,2,0
Jefferson2000 (29060/785),362,paroxetine,23,103,2001,1,1,2,0
Jefferson2000 (29060/785),362,citalopram,43,207,2001,1,1,2,0
Trivedi2004 (29060/810),363,placebo,36,149,2002,1,0,2,0
Trivedi2004 (29060/810),363,paroxetine,44,154,2002,1,1,2,0
Cassano2002 (29060/421),364,paroxetine,50,123,2002,1,1,2,0
Cassano2002 (29060/421),364,fluoxetine,45,119,2002,1,0,2,0
NKD20006 (NCT00048204),366,paroxetine,64,125,2003,1,1,2,1
NKD20006 (NCT00048204),366,placebo,40,125,2003,1,0,2,1
Rapaport2009 (BRL-29060/874) (NCT00067444),367,paroxetine,39,177,2004,1,1,2,0
Rapaport2009 (BRL-29060/874) (NCT00067444),367,placebo,53,180,2004,1,0,2,0
Katz2004,368,paroxetine,4,28,2004,0,3,1,0
Katz2004,368,placebo,5,25,2004,0,0,1,0
Dimidjian2006,369,paroxetine,44,100,2006,0,0,2,0
Dimidjian2006,369,placebo,12,53,2006,0,0,2,0
"Higuchi2011 (PCR112810, NCT00866294)",370,paroxetine,31,244,2010,1,1,1,0
"Higuchi2011 (PCR112810, NCT00866294)",370,placebo,33,172,2010,1,0,1,0
Learned2012b Study2 (NCT00420641),372,paroxetine,38,166,2012,0,1,2,0
Learned2012b Study2 (NCT00420641),372,placebo,41,156,2012,0,0,2,0
MY-1008/BRL-029060/2/CPMS-076 ,373,paroxetine,1,4,1991,1,1,2,1
MY-1008/BRL-029060/2/CPMS-076 ,373,placebo,1,4,1991,1,0,2,1
Deushle 2003(NCT01049347),374,amitriptyline,8,14,1997,0,0,3,0
Deushle 2003(NCT01049347),374,paroxetine,6,21,1997,0,0,3,0
Keller2006a (Study059) (NCT00035009),375,paroxetine,45,154,2003,0,0,2,0
Keller2006a (Study059) (NCT00035009),375,placebo,46,155,2003,0,0,2,0
Keller2006b (Study061) (NCT00035295),376,paroxetine,43,143,2003,0,0,2,0
Keller2006b (Study061) (NCT00035295),376,placebo,45,145,2003,0,0,2,0
Keller2006c (Study062) (NCT00048607),377,paroxetine,33,164,2003,0,0,2,0
Keller2006c (Study062) (NCT00048607),377,placebo,48,161,2003,0,0,2,0
Griebel2012b (Study DF15879) (NCT00361491),378,paroxetine,16,80,2007,0,0,2,0
Griebel2012b (Study DF15879) (NCT00361491),378,placebo,22,79,2007,0,0,2,0
MDUK/26090/III/83/007 ,379,paroxetine,1,4,1983,1,1,2,1
MDUK/26090/III/83/007 ,379,placebo,1,3,1983,1,0,2,1
Versiani2000 (Study 091),380,reboxetine,4,28,1990,1,1,2,0
Versiani2000 (Study 091),380,placebo,16,28,1990,1,0,2,0
Study 015,382,reboxetine,23,112,1992,1,1,1,1
Study 015,382,placebo,26,112,1992,1,0,1,1
Bosc1997b (Study 016 - Massana 1999),383,reboxetine,20,79,1993,1,1,2,0
Bosc1997b (Study 016 - Massana 1999),383,fluoxetine,20,89,1993,1,0,2,0
Bosc1997a (Study 014 - Andreoli2002),384,reboxetine,38,126,1997,1,1,2,0
Bosc1997a (Study 014 - Andreoli2002),384,placebo,52,128,1997,1,0,2,0
Bosc1997a (Study 014 - Andreoli2002),384,fluoxetine,30,127,1997,1,0,2,0
Ban1998 (Study 008),385,reboxetine,8,84,1998,1,3,1,0
Ban1998 (Study 008),385,placebo,10,85,1998,1,0,1,0
Study 049,386,reboxetine,37,107,1998,1,1,2,1
Study 049,386,placebo,23,105,1998,1,0,2,1
Study 045,387,reboxetine,27,89,1999,1,1,2,1
Study 045,387,placebo,20,87,1999,1,0,2,1
Clayton2003 (Study 050),388,reboxetine,63,150,1999,1,1,2,0
Clayton2003 (Study 050),388,placebo,60,150,1999,1,0,2,0
Clayton2003 (Study 050),388,fluoxetine,47,150,1999,1,0,2,0
Baldwin2006a (97-CRBX-052 - Study 052),389,reboxetine,53,159,2000,1,1,2,0
Baldwin2006a (97-CRBX-052 - Study 052),389,paroxetine,33,166,2000,1,0,2,0
M/2020/0046 (Study 046),390,reboxetine,67,265,2000,1,1,2,1
M/2020/0046 (Study 046),390,placebo,40,257,2000,1,0,2,1
M/2020/0046 (Study 046),390,paroxetine,58,265,2000,1,0,2,1
M/2020/0047 (Study 047),391,reboxetine,69,258,2000,1,1,2,1
M/2020/0047 (Study 047),391,placebo,58,254,2000,1,0,2,1
M/2020/0047 (Study 047),391,paroxetine,74,262,2000,1,0,2,1
Study 043,392,reboxetine,44,183,2006,1,1,2,0
Study 043,392,citalopram,29,176,2006,1,0,2,0
Studie009 (CTN009-FCE20124),394,reboxetine,6,26,1989,1,1,1,1
Studie009 (CTN009-FCE20124),394,placebo,7,24,1989,1,0,1,1
Studie032 (M2020/0032),395,reboxetine,15,43,2001,1,1,1,1
Studie032 (M2020/0032),395,fluoxetine,13,42,2001,1,0,1,1
Reimherr1990 (SER 104 - FDA),396,amitriptyline,63,149,1990,1,0,2,0
Reimherr1990 (SER 104 - FDA),396,placebo,56,150,1990,1,0,2,0
Reimherr1990 (SER 104 - FDA),396,sertraline,61,149,1990,1,3,2,0
Cohn1990,397,sertraline,79,161,1990,0,3,2,0
Cohn1990,397,amitriptyline,41,80,1990,0,0,2,0
Aguglia1993,398,sertraline,17,52,1993,0,0,2,0
Aguglia1993,398,fluoxetine,31,56,1993,0,0,2,0
Bersani1994,399,sertraline,3,34,1994,0,3,2,0
Bersani1994,399,amitriptyline,4,34,1994,0,3,2,0
Moon1994,400,sertraline,4,51,1994,0,1,2,0
Moon1994,400,clomipramine,10,55,1994,0,0,2,0
Bennie1995,402,sertraline,24,142,1995,0,1,1,0
Bennie1995,402,fluoxetine,23,144,1995,0,0,1,0
vanMoffaert1995a,403,sertraline,14,83,1995,0,1,2,0
vanMoffaert1995a,403,fluoxetine,16,82,1995,0,0,2,0
Lydiard1997,404,amitriptyline,50,131,1997,0,0,2,0
Lydiard1997,404,placebo,37,129,1997,0,0,2,0
Lydiard1997,404,sertraline,36,132,1997,0,0,2,0
Ekselius1997,405,citalopram,31,200,1997,0,0,1,0
Ekselius1997,405,sertraline,41,200,1997,0,1,1,0
Moller1998 (Hegerl1997),407,amitriptyline,14,79,1997,0,0,1,0
Moller1998 (Hegerl1997),407,sertraline,17,81,1997,0,1,1,0
Newhouse2000,409,sertraline,37,117,2000,0,1,2,0
Newhouse2000,409,fluoxetine,39,119,2000,0,0,2,0
Aberg-Wisted2000,410,paroxetine,26,177,2000,0,0,1,0
Aberg-Wisted2000,410,sertraline,33,176,2000,0,0,1,0
Moller2000,411,sertraline,14,116,2000,0,1,1,0
Moller2000,411,amitriptyline,16,124,2000,0,0,1,0
Lepine2000,412,sertraline,13,82,2000,0,1,1,0
Lepine2000,412,clomipramine,19,84,2000,0,0,1,0
Sir2005,413,venlafaxine,25,84,2003,0,0,2,0
Sir2005,413,sertraline,13,79,2003,0,1,2,0
Shelton2006 (NCT00179283),414,venlafaxine,11,78,2003,1,3,2,0
Shelton2006 (NCT00179283),414,sertraline,19,82,2003,1,1,2,0
Schneider2003,415,sertraline,87,371,2003,0,1,1,0
Schneider2003,415,placebo,65,376,2003,0,0,1,0
Moscovitch2004,416,sertraline,20,93,2004,0,1,1,0
Moscovitch2004,416,placebo,19,94,2004,0,0,1,0
Barber2011,417,sertraline,22,55,2007,0,0,2,0
Barber2011,417,placebo,15,50,2007,0,0,2,0
Binnemann2008 (NCT00143091),418,sertraline,14,43,2008,1,1,2,0
Binnemann2008 (NCT00143091),418,placebo,12,39,2008,1,0,2,0
Brunoni2012,419,sertraline,6,30,2012,0,0,1,0
Brunoni2012,419,placebo,4,30,2012,0,0,1,0
SER 101 (FDA),420,sertraline,31,73,1991,1,1,3,1
SER 101 (FDA),420,placebo,8,26,1991,1,0,3,1
Fabre1995 (SER 103 FDA),421,sertraline,133,278,1991,1,1,2,0
Fabre1995 (SER 103 FDA),421,placebo,45,91,1991,1,0,2,0
SER 310 (FDA),422,sertraline,30,105,1991,1,1,2,1
SER 310 (FDA),422,placebo,8,34,1991,1,0,2,1
SER 315 (FDA),423,sertraline,38,85,1991,1,1,2,1
SER 315 (FDA),423,amitriptyline,28,77,1991,1,0,2,1
SER 315 (FDA),423,placebo,39,80,1991,1,0,2,1
Mao2015 (NCT01098318),424,sertraline,7,19,2013,0,0,2,0
Mao2015 (NCT01098318),424,placebo,3,18,2013,0,0,2,0
Mundt2012 (NCT00406952),425,sertraline,17,80,2007,0,1,2,0
Mundt2012 (NCT00406952),425,placebo,22,85,2007,0,0,2,0
Davidson2002 (HDTSG) (NCT00005013),426,sertraline,32,111,2002,0,3,1,0
Davidson2002 (HDTSG) (NCT00005013),426,placebo,32,116,2002,0,0,1,0
Olie1997,427,sertraline,27,129,1997,0,1,2,0
Olie1997,427,placebo,45,129,1997,0,0,2,0
Ravindran1995,429,sertraline,15,40,1995,0,1,2,0
Ravindran1995,429,placebo,13,26,1995,0,0,2,0
Lapierre1980,434,amitriptyline,2,20,1980,0,3,2,0
Lapierre1980,434,trazodone,1,20,1980,0,3,2,0
Feighner1980,435,trazodone,9,19,1980,0,1,2,0
Feighner1980,435,placebo,7,10,1980,0,0,2,0
Gerner1980,436,trazodone,6,19,1980,0,1,2,0
Gerner1980,436,placebo,6,20,1980,0,0,2,0
Blacker1988,441,amitriptyline,8,44,1988,0,0,2,0
Blacker1988,441,trazodone,28,112,1988,0,3,2,0
Altamura1989b,442,amitriptyline,5,37,1989,0,3,2,0
Altamura1989b,442,trazodone,4,36,1989,0,3,2,0
Kasper2005b,443,paroxetine,0,53,2005,0,3,2,0
Kasper2005b,443,trazodone,5,55,2005,0,3,2,0
Munizza2006,444,sertraline,8,60,2006,0,0,1,0
Munizza2006,444,trazodone,5,62,2006,0,1,1,0
Sheehan2009b (NCT00775203),445,trazodone,62,206,2009,1,1,2,0
Sheehan2009b (NCT00775203),445,placebo,43,206,2009,1,0,2,0
Rickels1982,446,amitriptyline,19,68,1982,0,0,2,0
Rickels1982,446,placebo,14,68,1982,0,0,2,0
Rickels1982,446,trazodone,16,66,1982,0,3,2,0
Zhang2014,447,trazodone,47,192,2014,0,0,1,0
Zhang2014,447,placebo,43,190,2014,0,0,1,0
0600A-654,451,venlafaxine,55,131,1993,1,1,2,1
0600A-654,451,fluoxetine,43,135,1993,1,0,2,1
Cunningham1994 (VEN 600A-302 FDA),454,venlafaxine,25,76,1994,1,1,2,0
Cunningham1994 (VEN 600A-302 FDA),454,trazodone,28,77,1994,1,0,2,0
Cunningham1994 (VEN 600A-302 FDA),454,placebo,27,76,1994,1,0,2,0
VEN 600A-303 (FDA),455,venlafaxine,35,83,1993,1,1,2,1
VEN 600A-303 (FDA),455,placebo,26,82,1993,1,0,2,1
VEN 600A-313 (FDA),456,venlafaxine,39,158,1993,1,1,2,1
VEN 600A-313 (FDA),456,placebo,25,79,1993,1,0,2,1
VEN XR 367 (FDA),457,venlafaxine,46,165,1993,1,1,2,1
VEN XR 367 (FDA),457,paroxetine,28,81,1993,1,0,2,1
VEN XR 367 (FDA),457,placebo,24,83,1993,1,0,2,1
Clerc1994,462,fluoxetine,12,34,1994,0,0,2,0
Clerc1994,462,venlafaxine,6,34,1994,0,1,2,0
Schweizer1994 (VEN 600A-301 FDA),463,venlafaxine,29,76,1994,1,1,2,0
Schweizer1994 (VEN 600A-301 FDA),463,placebo,21,78,1994,1,0,2,0
Guelfi1995 (VEN 600A-206 FDA),464,venlafaxine,11,46,1995,1,1,2,0
Guelfi1995 (VEN 600A-206 FDA),464,placebo,27,47,1995,1,0,2,0
Dierick1996,465,fluoxetine,40,161,1994,0,0,2,0
Dierick1996,465,venlafaxine,38,153,1994,0,1,2,0
Lecrubier1997,466,venlafaxine,23,78,1997,0,3,2,0
Lecrubier1997,466,placebo,19,76,1997,0,0,2,0
Cunningham1997 (VEN XR 208 - FDA),467,venlafaxine,66,193,1997,1,1,2,0
Cunningham1997 (VEN XR 208 - FDA),467,placebo,41,100,1997,1,0,2,0
Thase1997 (VEN XR 209 FDA),468,venlafaxine,26,95,1997,1,1,2,0
Thase1997 (VEN XR 209 FDA),468,placebo,41,102,1997,1,0,2,0
Tylee1997,469,fluoxetine,46,170,1997,0,0,2,0
Tylee1997,469,venlafaxine,47,171,1997,0,1,2,0
Hackett1998,470,fluvoxamine,13,34,1998,0,0,2,0
Hackett1998,470,venlafaxine,18,77,1998,0,1,2,0
Costaesilva1998,471,fluoxetine,18,186,1998,0,0,1,0
Costaesilva1998,471,venlafaxine,29,196,1998,0,1,1,0
McPartlin1998,472,paroxetine,52,178,1998,0,0,2,0
McPartlin1998,472,venlafaxine,47,183,1998,0,1,2,0
Samuelian1998,473,venlafaxine,18,52,1998,0,1,2,0
Samuelian1998,473,clomipramine,18,50,1998,0,0,2,0
Rudolph1998 (VEN 600A-203 (FDA),476,venlafaxine,126,266,1998,1,1,1,0
Rudolph1998 (VEN 600A-203 (FDA),476,placebo,38,92,1998,1,0,1,0
Alves1999,477,fluoxetine,9,47,1999,0,0,1,0
Alves1999,477,venlafaxine,10,40,1999,0,1,1,0
Rudolph1999,478,fluoxetine,28,103,1999,0,0,1,0
Rudolph1999,478,venlafaxine,19,100,1999,0,1,1,0
Rudolph1999,478,placebo,21,98,1999,0,0,1,0
Silverstone1999,479,fluoxetine,32,121,1999,0,0,2,0
Silverstone1999,479,venlafaxine,37,128,1999,0,1,2,0
Silverstone1999,479,placebo,48,119,1999,0,0,2,0
Mehtonen2000,480,sertraline,12,72,2000,0,0,1,0
Mehtonen2000,480,venlafaxine,16,75,2000,0,1,1,0
Tzanakaki2000,481,fluoxetine,12,54,2000,0,0,2,0
Tzanakaki2000,481,venlafaxine,12,55,2000,0,1,2,0
Gentil2000,482,venlafaxine,9,57,2000,0,1,1,0
Gentil2000,482,amitriptyline,8,59,2000,0,0,1,0
Casabona2002 (0600B 428),483,paroxetine,10,56,2002,1,0,1,0
Casabona2002 (0600B 428),483,venlafaxine,10,58,2002,1,1,1,0
Sauer2003,484,venlafaxine,19,79,2003,0,1,2,0
Sauer2003,484,amitriptyline,20,77,2003,0,0,2,0
Schatzberg2006a,486,fluoxetine,30,100,2006,0,0,2,0
Schatzberg2006a,486,venlafaxine,37,104,2006,0,1,2,0
Schatzberg2006a,486,placebo,23,96,2006,0,0,2,0
Nemeroff2007,487,fluoxetine,18,104,2007,0,3,2,0
Nemeroff2007,487,venlafaxine,24,102,2007,0,1,2,0
Nemeroff2007,487,placebo,24,102,2007,0,0,2,0
Sheehan2009a,489,fluoxetine,23,99,2009,0,0,1,0
Sheehan2009a,489,venlafaxine,29,95,2009,0,1,1,0
Sheehan2009a,489,placebo,28,95,2009,0,0,1,0
Hosseini2015 (IRCT201203048513N1.),493,venlafaxine,12,28,2011,0,0,2,0
Hosseini2015 (IRCT201203048513N1.),493,citalopram,2,25,2011,0,0,2,0
"Learned2012a Study1 (EUCTR2005-003401-87, SND103285, NCT00448058)",494,venlafaxine,50,134,2008,1,0,2,0
"Learned2012a Study1 (EUCTR2005-003401-87, SND103285, NCT00448058)",494,placebo,42,126,2008,1,0,2,0
Higuchi 2014(NCT01441440),495,venlafaxine,45,354,2011,1,1,1,0
Higuchi 2014(NCT01441440),495,placebo,17,184,2011,1,0,1,0
Heller2009(NCT00909155),496,venlafaxine,3,15,2009,1,1,2,0
Heller2009(NCT00909155),496,fluoxetine,5,14,2009,1,0,2,0
Rickels2009 (GNSC-04-DP-02 FDA) (NCT00285376),498,vilazodone,53,205,2007,0,1,2,0
Rickels2009 (GNSC-04-DP-02 FDA) (NCT00285376),498,placebo,51,205,2007,0,0,2,0
Khan2011 (CLDA-07-DP-02 FDA) (NCT00683592),499,vilazodone,47,240,2009,1,1,1,0
Khan2011 (CLDA-07-DP-02 FDA) (NCT00683592),499,placebo,46,241,2009,1,0,1,0
FDA 248 (SB 659746-002),504,vilazodone,42,132,2011,1,1,2,1
FDA 248 (SB 659746-002),504,placebo,31,128,2011,1,0,2,1
Croft2014 (NCT01473394),505,vilazodone,48,260,2013,0,1,1,0
Croft2014 (NCT01473394),505,placebo,50,258,2013,0,0,1,0
Mathews2015 (NCT01473381),506,vilazodone,195,583,2013,1,1,1,0
Mathews2015 (NCT01473381),506,placebo,80,290,2013,1,0,1,0
Mathews2015 (NCT01473381),506,citalopram,89,289,2013,1,0,1,0
"Alvarez2012 (11492A, NCT00839423)",508,placebo,18,105,2007,1,0,2,0
"Alvarez2012 (11492A, NCT00839423)",508,vortioxetine,30,210,2007,1,1,2,0
"Alvarez2012 (11492A, NCT00839423)",508,venlafaxine,20,114,2007,1,0,2,0
"Jain2013 (303, NCT00672958)",509,placebo,64,300,2008,1,0,1,0
"Jain2013 (303, NCT00672958)",509,vortioxetine,56,300,2008,1,1,1,0
"Mahableshwarkar2013 (304, NCT00672620)",510,placebo,33,153,2008,1,0,1,0
"Mahableshwarkar2013 (304, NCT00672620)",510,vortioxetine,31,153,2008,1,1,1,0
"Mahableshwarkar2013 (304, NCT00672620)",510,duloxetine,42,152,2008,1,0,1,0
"Baldwin2012 (11984A, NCT00635219)",511,placebo,29,152,2009,1,0,1,0
"Baldwin2012 (11984A, NCT00635219)",511,vortioxetine,73,312,2009,1,1,1,0
"Baldwin2012 (11984A, NCT00635219)",511,duloxetine,44,157,2009,1,0,1,0
"Henigsberg2012 (305, NCT00735709)",512,placebo,13,140,2009,1,0,1,0
"Henigsberg2012 (305, NCT00735709)",512,vortioxetine,29,280,2009,1,1,1,0
"Katona2012 (12541A, NCT00811252)",513,placebo,17,145,2010,1,0,1,0
"Katona2012 (12541A, NCT00811252)",513,vortioxetine,20,156,2010,1,1,1,0
"Katona2012 (12541A, NCT00811252)",513,duloxetine,23,151,2010,1,0,1,0
"Boulenger2014 (13267A, NCT01140906)",514,placebo,25,158,2011,1,0,2,0
"Boulenger2014 (13267A, NCT01140906)",514,vortioxetine,61,303,2011,1,1,2,0
"Boulenger2014 (13267A, NCT01140906)",514,duloxetine,16,147,2011,1,0,2,0
"Jacobsen2015 (316, NCT01163266)",515,placebo,18,157,2012,1,0,1,0
"Jacobsen2015 (316, NCT01163266)",515,vortioxetine,59,305,2012,1,1,1,0
"Mahableshwarkar2015a (315, NCT01153009)",516,placebo,32,161,2012,1,0,1,0
"Mahableshwarkar2015a (315, NCT01153009)",516,vortioxetine,75,301,2012,1,1,1,0
"Mahableshwarkar2015a (315, NCT01153009)",516,duloxetine,37,152,2012,1,0,1,0
"Mahableshwarkar2015b (317, NCT01179516)",517,placebo,27,160,2012,1,0,1,0
"Mahableshwarkar2015b (317, NCT01179516)",517,vortioxetine,57,309,2012,1,1,1,0
"NCT01355081(japicCTI-111492, U1111-1120-9277)",518,vortioxetine,17,242,2012,1,1,1,1
"NCT01355081(japicCTI-111492, U1111-1120-9277)",518,placebo,11,124,2012,1,0,1,1
"NCT01255787 (EUCTR2010-022257-41, Lu AA21004/CCT-002, U1111-1117-6595, JapicCTI-101344, CTRI/2011/08/001963)",519,placebo,16,152,2012,1,0,1,1
"NCT01255787 (EUCTR2010-022257-41, Lu AA21004/CCT-002, U1111-1117-6595, JapicCTI-101344, CTRI/2011/08/001963)",519,vortioxetine,57,448,2012,1,1,1,1
McIntyre2014 (NCT01422213),520,placebo,35,198,2013,1,0,1,0
McIntyre2014 (NCT01422213),520,vortioxetine,53,404,2013,1,1,1,0
"Wang2015 (NCT01571453, KCT0000432, 13926A)",521,vortioxetine,38,213,2013,1,1,1,0
"Wang2015 (NCT01571453, KCT0000432, 13926A)",521,venlafaxine,62,230,2013,1,0,1,0
Mahableshwarkar2015c (NCT01564862),522,vortioxetine,30,198,2014,1,1,1,0
Mahableshwarkar2015c (NCT01564862),522,duloxetine,34,210,2014,1,0,1,0
Mahableshwarkar2015c (NCT01564862),522,placebo,30,194,2014,1,0,1,0
